Clinical Trial Update: A Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 trial of BPS-314d-MR-PAH-303 in pulmonary arterial hypertension was terminated; results were posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• BPS-314d-MR-PAH-303

Snippet

Sponsor: Lung Biotechnology PBC | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: TERMINATED | Results posted: 2020-09-07